Work

Management of the Patient With HIV/Hepatitis C Drug Interactions: A Guide for Nurses and Nurse Practitioners

Year: 2019

Type: article

Abstract: Approximately one third of patients coinfected with HIV and hepatitis C virus (HCV) who initiate direct-acting antivirals (DAAs) for HCV treatment may have to switch antiretroviral therapy (ART) because of drug interactions. ART switches can negatively affect quality of life, increase HIV symptom burden, and delay HCV therapy. Approaches to identify ART/DAA drug interactions that minimize the impact of switching ART are urgently needed. Nurses can lead the way in addressing this new and major need. We provide a guide for registered nurses and nurse practitioners who care for patients coinfected with HIV and HCV to identify HIV/HCV drug interactions and manage ART/DAA coadministration when needed.

Source: Journal of the Association of Nurses in AIDS Care

DOI: 10.1097/jnc.0000000000000144

Authors: Laura E. Starbird, Hyejeong Hong, Mark S. Sulkowski, Jason E. Farley

Language: English

Topic: Hepatitis C virus research

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institute on Drug Abuse, National Institute of Nursing Research

Awards: G2456272280, Nurse Case Management to Improve Hepatitis C Linkage to Care and Treatment in HIV Coinfection, G6302187890, Systems Science and Comparative and Cost-Effectiveness Research Training for Nurse Scientists (S2CER2), Interdisciplinary Nurse Scientist Training in Multilevel Approaches: Biology to Society